Aurinia Pharmaceuticals (AUPH) Assets (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Aurinia Pharmaceuticals | 2.03 Bn | 1.65 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.67% |
| Dec 31, 2025 | 42.47% |
| Sep 30, 2025 | 4.97% |
| Jun 30, 2025 | -0.45% |
| Mar 31, 2025 | -8.32% |
| Dec 31, 2024 | 0.23% |
| Sep 30, 2024 | 4.93% |
| Jun 30, 2024 | 1.33% |
| Mar 31, 2024 | -5.73% |
| Dec 31, 2023 | -1.25% |
| Sep 30, 2023 | 1.11% |
| Jun 30, 2023 | 21.50% |
| Mar 31, 2023 | -4.06% |
| Dec 31, 2022 | -3.57% |
| Sep 30, 2022 | 1.27% |
| Jun 30, 2022 | -4.88% |
| Mar 31, 2022 | -6.71% |
| Dec 31, 2021 | 50.91% |
| Sep 30, 2021 | -6.78% |
| Jun 30, 2021 | -7.39% |
| Mar 31, 2021 | -10.05% |
| Dec 31, 2020 | 0.41% |
| Sep 30, 2020 | 66.09% |
| Jun 30, 2020 | -6.67% |
| Mar 31, 2020 | -8.14% |
| Dec 31, 2019 | 114.99% |
| Sep 30, 2019 | -0.26% |
| Jun 30, 2019 | -8.06% |
| Mar 31, 2019 | 12.78% |
| Dec 31, 2018 | -7.50% |
| Sep 30, 2018 | -6.05% |
| Jun 30, 2018 | -4.85% |
| Mar 31, 2018 | -7.08% |
| Dec 31, 2017 | -5.00% |
| Sep 30, 2017 | -3.83% |
| Jun 30, 2017 | -5.41% |
| Mar 31, 2017 | 285.45% |
| Dec 31, 2016 | 71.42% |
| Sep 30, 2016 | 10.15% |
| Jun 30, 2016 | 8.78% |
| Mar 31, 2016 | -17.33% |
| Dec 31, 2015 | -13.80% |
| Sep 30, 2015 | -12.26% |
| Jun 30, 2015 | -7.55% |